Ruxolitinib for the treatment of steroid refractory pediatric chronic graft‐versus‐host disease
Year: 2022
Type: article
Study design: Case Report
Source: Pediatric Dermatology
DOI: 10.1111/pde.14965
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4214897664
